Guardant Health Statistics
Total Valuation
GH has a market cap or net worth of $2.11 billion. The enterprise value is $2.27 billion.
| Market Cap | 2.11B |
| Enterprise Value | 2.27B |
Important Dates
The next confirmed earnings date is Thursday, May 9, 2024, after market close.
| Earnings Date | May 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
GH has 121.71 million shares outstanding. The number of shares has increased by 9.60% in one year.
| Shares Outstanding | 121.71M |
| Shares Change (YoY) | +9.60% |
| Shares Change (QoQ) | +0.72% |
| Owned by Insiders (%) | 4.15% |
| Owned by Institutions (%) | 93.49% |
| Float | 109.64M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.74 |
| Forward PS | 3.09 |
| PB Ratio | 13.31 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.02 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.54, with a Debt / Equity ratio of 8.36.
| Current Ratio | 6.54 |
| Quick Ratio | 6.11 |
| Debt / Equity | 8.36 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -184.71 |
Financial Efficiency
Return on equity (ROE) is -301.90% and return on invested capital (ROIC) is -38.04%.
| Return on Equity (ROE) | -301.90% |
| Return on Assets (ROA) | -27.70% |
| Return on Capital (ROIC) | -38.04% |
| Revenue Per Employee | $317,003 |
| Profits Per Employee | -$269,505 |
| Employee Count | 1,779 |
| Asset Turnover | 0.33 |
| Inventory Turnover | 4.00 |
Taxes
In the past 12 months, GH has paid $685,000 in taxes.
| Income Tax | 685,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -17.14% in the last 52 weeks. The beta is 0.90, so GH's price volatility has been lower than the market average.
| Beta (1Y) | 0.90 |
| 52-Week Price Change | -17.14% |
| 50-Day Moving Average | 18.77 |
| 200-Day Moving Average | 26.38 |
| Relative Strength Index (RSI) | 46.10 |
| Average Volume (30 Days) | 1,994,511 |
Short Selling Information
The latest short interest is 9.56 million, so 7.85% of the outstanding shares have been sold short.
| Short Interest | 9.56M |
| Short Previous Month | 7.64M |
| Short % of Shares Out | 7.85% |
| Short % of Float | 8.72% |
| Short Ratio (days to cover) | 3.93 |
Income Statement
In the last 12 months, GH had revenue of $563.95 million and -$479.45 million in losses. Loss per share was -$4.28.
| Revenue | 563.95M |
| Gross Profit | 336.90M |
| Operating Income | -564.73M |
| Pretax Income | -478.76M |
| Net Income | -479.45M |
| EBITDA | -433.31M |
| EBIT | -476.19M |
| Loss Per Share | -$4.28 |
Balance Sheet
The company has $1.17 billion in cash and $1.33 billion in debt, giving a net cash position of -$157.18 million or -$1.29 per share.
| Cash & Cash Equivalents | 1.17B |
| Total Debt | 1.33B |
| Net Cash | -157.18M |
| Net Cash Per Share | -$1.29 |
| Equity / Book Value | 158.68M |
| Book Value Per Share | 1.30 |
| Working Capital | 1.14B |
Cash Flow
In the last 12 months, operating cash flow was -$324.98 million and capital expenditures -$20.49 million, giving a free cash flow of -$345.46 million.
| Operating Cash Flow | -324.98M |
| Capital Expenditures | -20.49M |
| Free Cash Flow | -345.46M |
| FCF Per Share | -$3.09 |
Margins
Gross margin is 59.74%, with operating and profit margins of -100.14% and -85.02%.
| Gross Margin | 59.74% |
| Operating Margin | -100.14% |
| Pretax Margin | -84.90% |
| Profit Margin | -85.02% |
| EBITDA Margin | -76.83% |
| EBIT Margin | -84.44% |
| FCF Margin | -61.26% |
Dividends & Yields
GH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.60% |
| Shareholder Yield | -9.60% |
| Earnings Yield | -22.70% |
| FCF Yield | -16.36% |
Analyst Forecast
The average price target for GH is $39.20, which is 125.94% higher than the current price. The consensus rating is "Buy".
| Price Target | $39.20 |
| Price Target Difference | 125.94% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (5Y) | 27.16% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
GH has an Altman Z-Score of -0.7 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.7 |
| Piotroski F-Score | 4 |